Specialty Services at the UPMC Center for Liver Diseases
The complexity of liver disease requires care that is both collaborative and individualized to each person’s needs.
At the UPMC Center for Liver Diseases, our patients benefit from this coordinated treatment approach and from our multidisciplinary specialty services.
Coordinated Care With Other UPMC Specialists
Because of our multidisciplinary approach to patient care, our liver disease doctors, also known as hepatologists, collaborate with specialists such as:
- Liver surgeons
- Gastrointestinal therapeutic endoscopists
- Interventional radiologists
- Medical and radiation oncologists
- Liver pathologists
- Clinical pharmacists
- Social workers
This ensures you receive consistent and convenient care, even when you require complex treatment.
Behavioral Health Consultations for People With Liver Disease
People diagnosed with liver disease often have difficulty coping with this life-changing diagnosis and the impact of treatment on their quality of life.
Our state-of-the-art Visceral Inflammation and Pain (VIP) Center is designed to treat the psychological impact of liver disease with:
- Cognitive behavioral therapy
- Relaxation techniques
Expertise in Liver Transplantation
When liver disease advances beyond the effectiveness of medical treatments, liver transplantation can be a life-saving option. UPMC surgeons are leading experts in liver transplantation as part of the Thomas E. Starzl Transplantation Institute, a nationally regarded center of excellence.
Fatty Liver Disease Specialized Care and Research
The hepatologists at UPMC’s Center for Liver Diseases provide individualized care in our Fatty Liver Clinic. They also conduct research into genetic factors that can predict disease progression of both alcohol influenced and non-alcohol related fatty liver disease.
Research Leadership in New Hepatitis C Treatment
Hepatologists at UPMC's Center for Liver Diseases have been involved from the earliest stages in researching new treatments for viral hepatitis C — a disease that affects about 3.2 million Americans.
These medications — known as protease inhibitors and polymerase inhibitors — are now being used, resulting in higher cure rates of hepatitis C.
Alpha-1 Antritrypsin Deficiency Research
In collaboration with Children’s Hospital of Pittsburgh of UPMC, our liver disease doctors are investigating a new treatment for Alpha-1 antritrypsin deficiency — a rare genetic liver disorder, which currently is not treatable.
UPMC is the only center in the country participating in this research study.